Concord Biotech has announced a final dividend of ₹10.70 per share. The ex-date for this dividend is due tomorrow, September 3, 2025. This makes today the last day to trade the stock before it turns ex-dividend; those investors who hold the shares today will be eligible to receive the dividend.
The company's last traded price was Rs 1,685.90 as of Monday's close, reflecting a 0.25% increase compared to the previous day. The company has a market capitalization of approximately 17,637.24 Crore.Here are the key details regarding the dividend announcement:
Dividend DetailsParticulars
Details
Dividend per share
₹10.70Ex-Date
September 3, 2025
Financial Performance Overview:
A review of Concord Biotech's recent financial performance reveals the following quarterly data. All figures are consolidated. The net profit for the quarter ending June 2025 stood at ₹42 crore. The Earnings Per Share (EPS) for the same period was ₹4.21. Comparatively, the net profit for the quarter ending March 2025 was ₹141 crore with an EPS of ₹13.42.
Additionally, the company's quarterly income statement provides further insights into its financial activities. The total income for the quarter ending June 2025 was ₹10 crore, with total expenditure at ₹86 crore. The Profit Before Tax (PBT) was ₹78 crore, and the net profit was ₹58 crore.